Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
muhammad Abdullah (lahore, Pakistan), Muhammad Abdullah, Shoaib Alam, Waleed Zafar, Abdul Majid, Ali Saeed Wahla. Diffusion lung capacity changes in Hodgkin lymphoma patients before and after ABVD chemotherapy. Eur Respir J 2015; 46: Suppl. 59, 963

Member's Comments

No comment yet.

Related content which might interest you: Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016 Pulmonary function changes after chemotherapy and radiotherapy for Lymphoma. Source: International Congress 2017 – Case reports and series Year: 2017 Lung resistance-related protein in lung cancer and lung lesions in Hodgkin disease Source: Eur Respir J 2006; 28: Suppl. 50, 86s Year: 2006 Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 A case of Non-Hodgkin lyphoma mimicking diffuse parenchymal lung disease Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 6 Year: 2014 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Pemetrexed in advanced non-small cell lung cancer patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 The role of CCR2+CD4+T cells in lung fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 A case series of eight patients treated with alectinib including a case of interstitial lung disease Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Beneficial effect of azithromycin in children with diffuse parenchymal lung disease Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014 Pulmonary function changes during treatment with rituximab in patients with rheumatoid arthritis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 What predicts radiation pneumonitis best? Pulmonary injury after curatively intended radiotherapy of early-stage lung cancer Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Our results of stereotactic radiotherapy in advanced stage lung cancer patients Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014